-
Mashup Score: 3Treatment De-escalation for Favorable Risk Breast Cancer | Podcast | ASCO Publications - 16 hour(s) ago
Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, shared decision making, and improved quality of life. This discussion will be based off a JCO OP editorial published in late 2024 called “Contextual Framework for Understanding Treatment De-Escalation in Patients With Breast Cancer.”
Source: ascopubs.orgCategories: General Medicine NewsTweet
-
Mashup Score: 1
This randomized trial examines whether notifying oncologists about genomically targeted clinical trials for eligible patients identified by artificial intelligence (AI) affects clinical trial participation.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
📄: https://t.co/dvmE9v5bbl Editorial: https://t.co/9QkAw0OCAg Identifying the appropriate target for an AI intervention in a health care system is of utmost importance... socioeconomic, behavioral, and systemic issues [are] not easily navigable with technology as it stands.
-
-
Mashup Score: 3
This risk model projects how many future cancers in the United States could result from annual computed tomography examinations.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
CT could be responsible for approximately 5% of cancers diagnosed each year. This would place CT on par with other significant risk factors, such as alcohol consumption (5.4%) and excess body weight (7.6%). https://t.co/iYdS9q2Mbx
-
-
Mashup Score: 3
This risk model projects how many future cancers in the United States could result from annual computed tomography examinations.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
CT could be responsible for approximately 5% of cancers diagnosed each year. This would place CT on par with other significant risk factors, such as alcohol consumption (5.4%) and excess body weight (7.6%). https://t.co/iYdS9q2Mbx
-
-
Mashup Score: 3
This risk model projects how many future cancers in the United States could result from annual computed tomography examinations.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
CT could be responsible for approximately 5% of cancers diagnosed each year. This would place CT on par with other significant risk factors, such as alcohol consumption (5.4%) and excess body weight (7.6%). https://t.co/iYdS9q2Mbx
-
-
Mashup Score: 3
This risk model projects how many future cancers in the United States could result from annual computed tomography examinations.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
CT could be responsible for approximately 5% of cancers diagnosed each year. This would place CT on par with other significant risk factors, such as alcohol consumption (5.4%) and excess body weight (7.6%). https://t.co/iYdS9q2Mbx
-
-
Mashup Score: 45Representation of Radiation Oncologists on National Comprehensive Cancer Network Guideline Committees - 15 day(s) ago
The National Comprehensive Cancer Network (NCCN) guideline committees play a vital role in defining the standard of care for cancer management. Equitable specialty representation is crucial for unbiased recommendations and perspectives. This study examines the specialty and leadership representation on NCCN guideline committees, with a focus on radiation oncologists (RO).
Source: www.advancesradonc.orgCategories: General Medicine NewsTweet-
#Radonc representation on @NCCN Treatment Guideline Committees is <10%, even for committees that recommend #radiation. Additionally, certain institutions have nominated relatively few ☢️👩⚕️ for their designated slots. Glad to see this📰 finally published. https://t.co/htGktHEQkm https://t.co/RsccQlFJvC
-
-
Mashup Score: 3
This cross-sectional study investigates whether differences in radiotherapy technologies, treatment length, and spending exist between traditional Medicare and Medicare Advantage beneficiaries with cancer.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
#medicareAdvantage pts with cancer undergoing #radiotherapy had HIGHER estimated spending & greater mean treatment length. Despite lower utilization of more expensive advanced treatment modalities, MA was NOT associated with cost savings. @JAMANetworkOpen https://t.co/upZ2F3eGxk
-
-
Mashup Score: 9Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials | JCO Oncology Practice - 19 day(s) ago
PURPOSEThis study aimed to determine complete toxicity reporting (CTR), and the use of subjective toxicity-minimizing language (TML) among phase III oncology trials.METHODSTwo-arm superiority-design phase III oncology trials published from 2002 to 2020 …
Source: ascopubs.orgCategories: General Medicine NewsTweet-
Toxicity in phase III oncology #clinicaltrials is often incompletely reported & is frequently minimized in its interpretation. Only 1/3 reported Grade 1 to 2 toxicities & toxicity-minimizing language was used in 46% (subjectively downplay the harm of tx) https://t.co/PAdTL4v2zC https://t.co/bwoWb0x6G4
-
-
Mashup Score: 1Affording Childcare on a Surgical Resident’s Salary - 23 day(s) ago
This cross-sectional study evaluates surgical residents’ net financial balance after childcare costs at various postgraduate years and child ages.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
🍼👶👨🍼 @JAMANetworkOpen manuscript: https://t.co/SugqQAtIp1 @WomeninOnc article: https://t.co/UFFUYaDkIF
-
https://t.co/JUi6XiA2Ct I speak with Dr @theRADSofKHAN & @DrLolaFayanju about the shift in #breastcancer management from reducing locoregional recurrence & improving #bcsm mortality to deintensification, shared decision making, & improved quality of life. @ASCO @JCOOP_ASCO